Johnson & Johnson (NYSE:JNJ) reported quarterly earnings of $2.70 per share which beat the analyst consensus estimate of $2.67 by 1.12 percent. This is a 2.53 percent decrease over earnings of $2.77 per share from the same period last year. The company reported quarterly sales of $24.062 billion which beat the analyst consensus estimate of $23.630 billion by 1.83 percent. This is a 9.91 percent increase over sales of $21.893 billion the same period last year.